These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects. Favre R, Cherif Y, Kohler M, Kohler A, Hunsinger MC, Bouffet N, Tanghe M, Cancellier M, Nisand I. Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217 [Abstract] [Full Text] [Related]
3. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ghi T, Huggon IC, Zosmer N, Nicolaides KH. Ultrasound Obstet Gynecol; 2001 Dec; 18(6):610-4. PubMed ID: 11844199 [Abstract] [Full Text] [Related]
6. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects]. Baś-Budecka E, Perenc M, Sieroszewski P. Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599 [Abstract] [Full Text] [Related]
7. Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation. Galindo A, Comas C, Martínez JM, Gutiérrez-Larraya F, Carrera JM, Puerto B, Borrell A, Mortera C, de la Fuente P. J Matern Fetal Neonatal Med; 2003 Mar; 13(3):163-70. PubMed ID: 12820838 [Abstract] [Full Text] [Related]
9. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. BMJ; 1999 Jan 09; 318(7176):81-5. PubMed ID: 9880278 [Abstract] [Full Text] [Related]
11. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Hyett JA, Perdu M, Sharland GK, Snijders RS, Nicolaides KH. Ultrasound Obstet Gynecol; 1997 Oct 09; 10(4):242-6. PubMed ID: 9383874 [Abstract] [Full Text] [Related]
12. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population. Schwärzler P, Carvalho JS, Senat MV, Masroor T, Campbell S, Ville Y. Br J Obstet Gynaecol; 1999 Oct 09; 106(10):1029-34. PubMed ID: 10519427 [Abstract] [Full Text] [Related]
16. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. Ultrasound Obstet Gynecol; 2001 Jul 09; 18(1):9-17. PubMed ID: 11489218 [Abstract] [Full Text] [Related]
17. Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation. Brady AF, Pandya PP, Yuksel B, Greenough A, Patton MA, Nicolaides KH. J Med Genet; 1998 Mar 09; 35(3):222-4. PubMed ID: 9541107 [Abstract] [Full Text] [Related]
19. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies. Müller MA, Clur SA, Timmerman E, Bilardo CM. Prenat Diagn; 2007 Feb 09; 27(2):164-9. PubMed ID: 17238215 [Abstract] [Full Text] [Related]
20. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH. Ultrasound Obstet Gynecol; 1998 Jun 09; 11(6):391-400. PubMed ID: 9674084 [Abstract] [Full Text] [Related] Page: [Next] [New Search]